| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fallopian Tube Neoplasms | 50 | 2024 | 329 | 11.800 |
Why?
|
| Cystadenocarcinoma, Serous | 44 | 2024 | 480 | 9.200 |
Why?
|
| Papillomaviridae | 136 | 2023 | 1140 | 7.830 |
Why?
|
| Uterine Cervical Neoplasms | 139 | 2023 | 2044 | 7.000 |
Why?
|
| Carcinoma in Situ | 53 | 2022 | 789 | 6.150 |
Why?
|
| Uterine Cervical Dysplasia | 58 | 2015 | 391 | 5.940 |
Why?
|
| Ovarian Neoplasms | 78 | 2024 | 4907 | 4.900 |
Why?
|
| Tumor Virus Infections | 70 | 2008 | 438 | 4.550 |
Why?
|
| Precancerous Conditions | 53 | 2021 | 984 | 4.290 |
Why?
|
| Vulvar Neoplasms | 36 | 2020 | 266 | 3.890 |
Why?
|
| Fallopian Tubes | 25 | 2023 | 179 | 3.720 |
Why?
|
| Papillomavirus Infections | 60 | 2023 | 1640 | 3.390 |
Why?
|
| Pelvic Neoplasms | 11 | 2013 | 250 | 2.630 |
Why?
|
| Tumor Suppressor Protein p53 | 37 | 2020 | 2952 | 1.830 |
Why?
|
| Carcinoma | 21 | 2022 | 2341 | 1.760 |
Why?
|
| Cervix Uteri | 35 | 2017 | 577 | 1.720 |
Why?
|
| Carcinoma, Squamous Cell | 45 | 2019 | 4069 | 1.700 |
Why?
|
| Genes, BRCA1 | 21 | 2013 | 755 | 1.680 |
Why?
|
| Peritoneal Neoplasms | 11 | 2024 | 715 | 1.660 |
Why?
|
| Carcinoma, Endometrioid | 8 | 2020 | 276 | 1.660 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 18 | 2019 | 710 | 1.620 |
Why?
|
| Uterine Cervical Diseases | 18 | 2020 | 75 | 1.550 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 6 | 2020 | 196 | 1.470 |
Why?
|
| Genes, BRCA2 | 19 | 2013 | 592 | 1.460 |
Why?
|
| DNA, Viral | 55 | 2016 | 2205 | 1.420 |
Why?
|
| Condylomata Acuminata | 26 | 1998 | 79 | 1.370 |
Why?
|
| PAX2 Transcription Factor | 8 | 2014 | 86 | 1.320 |
Why?
|
| Cell Transformation, Neoplastic | 25 | 2015 | 2846 | 1.320 |
Why?
|
| Ki-67 Antigen | 23 | 2019 | 628 | 1.280 |
Why?
|
| Genital Neoplasms, Female | 16 | 2024 | 539 | 1.250 |
Why?
|
| Immunohistochemistry | 50 | 2024 | 11120 | 1.160 |
Why?
|
| Vaginal Smears | 22 | 2008 | 505 | 1.120 |
Why?
|
| Epithelial Cells | 15 | 2023 | 3695 | 1.090 |
Why?
|
| Genes, p53 | 13 | 2018 | 716 | 1.080 |
Why?
|
| Neoplasms, Squamous Cell | 6 | 2014 | 95 | 1.080 |
Why?
|
| Female | 352 | 2024 | 397089 | 0.920 |
Why?
|
| Endometrial Neoplasms | 16 | 2019 | 1382 | 0.910 |
Why?
|
| Endometrium | 13 | 2021 | 407 | 0.900 |
Why?
|
| Neoplastic Stem Cells | 6 | 2018 | 1356 | 0.900 |
Why?
|
| Polyploidy | 2 | 2024 | 120 | 0.890 |
Why?
|
| Polymerase Chain Reaction | 26 | 2010 | 6085 | 0.880 |
Why?
|
| Neoplasms, Glandular and Epithelial | 6 | 2018 | 489 | 0.830 |
Why?
|
| Uterine Neoplasms | 20 | 2020 | 1427 | 0.790 |
Why?
|
| Trans-Activators | 11 | 2014 | 2856 | 0.740 |
Why?
|
| Phosphoproteins | 10 | 2014 | 2448 | 0.740 |
Why?
|
| Anus Neoplasms | 4 | 2019 | 337 | 0.740 |
Why?
|
| Genital Diseases, Female | 7 | 2015 | 193 | 0.710 |
Why?
|
| Human papillomavirus 6 | 2 | 2019 | 16 | 0.700 |
Why?
|
| Metaplasia | 18 | 2020 | 326 | 0.670 |
Why?
|
| Humans | 375 | 2024 | 768393 | 0.670 |
Why?
|
| Human papillomavirus 16 | 6 | 2019 | 268 | 0.660 |
Why?
|
| Mutation | 40 | 2019 | 30228 | 0.640 |
Why?
|
| Vulvar Diseases | 5 | 2021 | 64 | 0.640 |
Why?
|
| Vulva | 6 | 2018 | 84 | 0.630 |
Why?
|
| Endometriosis | 7 | 2021 | 875 | 0.630 |
Why?
|
| Biopsy | 33 | 2021 | 6808 | 0.590 |
Why?
|
| Loss of Heterozygosity | 5 | 2010 | 663 | 0.560 |
Why?
|
| Adenocarcinoma, Clear Cell | 2 | 2018 | 218 | 0.550 |
Why?
|
| Keratin-7 | 1 | 2016 | 55 | 0.550 |
Why?
|
| beta Catenin | 2 | 2020 | 1047 | 0.540 |
Why?
|
| BRCA1 Protein | 7 | 2015 | 1155 | 0.540 |
Why?
|
| BRCA2 Protein | 6 | 2015 | 802 | 0.530 |
Why?
|
| Epithelium | 21 | 2021 | 1609 | 0.520 |
Why?
|
| Neoplasm, Residual | 4 | 2014 | 1019 | 0.520 |
Why?
|
| Cell Lineage | 8 | 2018 | 2574 | 0.510 |
Why?
|
| Tumor Escape | 1 | 2018 | 372 | 0.510 |
Why?
|
| Neoplasm Recurrence, Local | 13 | 2022 | 9433 | 0.510 |
Why?
|
| Adenocarcinoma | 19 | 2023 | 6406 | 0.500 |
Why?
|
| Mucous Membrane | 4 | 2017 | 659 | 0.490 |
Why?
|
| Ovarian Cysts | 2 | 2020 | 108 | 0.470 |
Why?
|
| Viral Vaccines | 3 | 2006 | 596 | 0.470 |
Why?
|
| Ovary | 9 | 2019 | 960 | 0.470 |
Why?
|
| Oncogene Proteins, Viral | 11 | 2015 | 342 | 0.450 |
Why?
|
| Neoplasms, Multiple Primary | 7 | 2010 | 594 | 0.440 |
Why?
|
| Mass Screening | 10 | 2012 | 5451 | 0.430 |
Why?
|
| Immunoenzyme Techniques | 21 | 2014 | 1705 | 0.430 |
Why?
|
| CA-125 Antigen | 3 | 2012 | 281 | 0.430 |
Why?
|
| Stem Cells | 12 | 2023 | 3539 | 0.420 |
Why?
|
| In Situ Hybridization | 16 | 2015 | 1905 | 0.420 |
Why?
|
| Early Detection of Cancer | 4 | 2017 | 3236 | 0.410 |
Why?
|
| Nucleic Acid Hybridization | 20 | 2010 | 1305 | 0.400 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 906 | 0.400 |
Why?
|
| Barrett Esophagus | 6 | 2019 | 494 | 0.400 |
Why?
|
| Cyclin E | 5 | 2007 | 156 | 0.380 |
Why?
|
| Peritoneum | 4 | 2020 | 231 | 0.380 |
Why?
|
| Ovariectomy | 8 | 2013 | 615 | 0.380 |
Why?
|
| Endometrial Hyperplasia | 4 | 2010 | 99 | 0.380 |
Why?
|
| Observer Variation | 14 | 2021 | 2623 | 0.370 |
Why?
|
| Tumor Suppressor Proteins | 9 | 2020 | 2812 | 0.370 |
Why?
|
| Genes, Tumor Suppressor | 6 | 2008 | 1064 | 0.360 |
Why?
|
| Cell Proliferation | 12 | 2020 | 10478 | 0.360 |
Why?
|
| Adnexa Uteri | 2 | 2019 | 40 | 0.350 |
Why?
|
| Adult | 111 | 2024 | 223640 | 0.340 |
Why?
|
| Carbonic Anhydrases | 3 | 2001 | 108 | 0.340 |
Why?
|
| Membrane Proteins | 10 | 2013 | 7880 | 0.330 |
Why?
|
| Oropharynx | 1 | 2010 | 138 | 0.330 |
Why?
|
| Hysterectomy | 9 | 2014 | 864 | 0.330 |
Why?
|
| Diethylstilbestrol | 2 | 2008 | 87 | 0.320 |
Why?
|
| Antigens, Neoplasm | 7 | 2008 | 1999 | 0.320 |
Why?
|
| Lichen Sclerosus et Atrophicus | 2 | 2000 | 26 | 0.310 |
Why?
|
| Middle Aged | 88 | 2024 | 223491 | 0.310 |
Why?
|
| Papillomavirus Vaccines | 2 | 2006 | 497 | 0.310 |
Why?
|
| DNA, Neoplasm | 15 | 2010 | 1748 | 0.310 |
Why?
|
| Gene Expression Regulation, Neoplastic | 16 | 2020 | 8634 | 0.300 |
Why?
|
| Immunophenotyping | 7 | 2014 | 1866 | 0.300 |
Why?
|
| Uterine Diseases | 3 | 2003 | 108 | 0.300 |
Why?
|
| Diagnosis, Differential | 26 | 2024 | 13020 | 0.290 |
Why?
|
| Predictive Value of Tests | 19 | 2024 | 15455 | 0.290 |
Why?
|
| Mucins | 3 | 2000 | 571 | 0.290 |
Why?
|
| Neoplasm Proteins | 9 | 2020 | 3610 | 0.280 |
Why?
|
| Disease Progression | 11 | 2016 | 13646 | 0.280 |
Why?
|
| Placenta | 8 | 2014 | 1723 | 0.270 |
Why?
|
| Urologic Diseases | 1 | 2008 | 247 | 0.260 |
Why?
|
| Nuclear Proteins | 9 | 2024 | 5800 | 0.260 |
Why?
|
| Adenocarcinoma, Mucinous | 3 | 2013 | 526 | 0.260 |
Why?
|
| Carcinoma, Adenosquamous | 3 | 2001 | 67 | 0.260 |
Why?
|
| PTEN Phosphohydrolase | 6 | 2013 | 1119 | 0.250 |
Why?
|
| Trophoblasts | 4 | 2014 | 223 | 0.250 |
Why?
|
| Endocrine Disruptors | 1 | 2008 | 264 | 0.250 |
Why?
|
| Aged | 64 | 2024 | 171562 | 0.240 |
Why?
|
| DNA Probes, HPV | 8 | 2005 | 21 | 0.240 |
Why?
|
| Genes, Neoplasm | 1 | 2007 | 370 | 0.240 |
Why?
|
| Vaginal Diseases | 2 | 2020 | 103 | 0.240 |
Why?
|
| Cell Differentiation | 17 | 2020 | 11668 | 0.240 |
Why?
|
| Chlamydia Infections | 5 | 1987 | 365 | 0.240 |
Why?
|
| Embryonic and Fetal Development | 2 | 2002 | 420 | 0.230 |
Why?
|
| Acanthosis Nigricans | 1 | 2004 | 47 | 0.230 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2010 | 493 | 0.230 |
Why?
|
| High-Throughput Nucleotide Sequencing | 9 | 2020 | 3666 | 0.230 |
Why?
|
| DNA-Binding Proteins | 14 | 2020 | 9614 | 0.230 |
Why?
|
| Carcinoma, Verrucous | 1 | 2004 | 26 | 0.230 |
Why?
|
| Stathmin | 2 | 2015 | 70 | 0.230 |
Why?
|
| Uterus | 3 | 2022 | 661 | 0.220 |
Why?
|
| Genetic Predisposition to Disease | 13 | 2018 | 18048 | 0.220 |
Why?
|
| Trophoblastic Neoplasms | 3 | 2015 | 89 | 0.220 |
Why?
|
| Vaccines, Synthetic | 1 | 2006 | 622 | 0.220 |
Why?
|
| Bowen's Disease | 3 | 1996 | 13 | 0.220 |
Why?
|
| DNA Mutational Analysis | 10 | 2019 | 4120 | 0.220 |
Why?
|
| Neoplasms, Second Primary | 2 | 2007 | 1060 | 0.220 |
Why?
|
| Microsatellite Repeats | 3 | 2000 | 784 | 0.210 |
Why?
|
| Keratosis, Seborrheic | 1 | 2003 | 29 | 0.210 |
Why?
|
| Vaginal Neoplasms | 4 | 2020 | 105 | 0.210 |
Why?
|
| Adnexal Diseases | 2 | 2024 | 105 | 0.210 |
Why?
|
| Hydatidiform Mole | 5 | 2014 | 255 | 0.210 |
Why?
|
| Herpes Simplex Virus Vaccines | 1 | 2002 | 17 | 0.210 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2024 | 211 | 0.200 |
Why?
|
| Urogenital System | 1 | 2002 | 88 | 0.200 |
Why?
|
| Aged, 80 and over | 26 | 2024 | 59686 | 0.200 |
Why?
|
| RNA, Viral | 8 | 2015 | 2866 | 0.200 |
Why?
|
| Pathology, Surgical | 1 | 2003 | 150 | 0.200 |
Why?
|
| Herpes Genitalis | 2 | 2002 | 149 | 0.200 |
Why?
|
| Disease Management | 1 | 2013 | 2537 | 0.200 |
Why?
|
| Germ Cells | 2 | 2010 | 643 | 0.200 |
Why?
|
| Peritoneal Cavity | 1 | 2022 | 135 | 0.200 |
Why?
|
| Peritoneal Diseases | 2 | 2021 | 76 | 0.200 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2024 | 3794 | 0.200 |
Why?
|
| Colposcopy | 9 | 2002 | 151 | 0.200 |
Why?
|
| Esophagus | 4 | 2019 | 1042 | 0.190 |
Why?
|
| Catheter Ablation | 1 | 2015 | 2776 | 0.190 |
Why?
|
| Hyperplasia | 7 | 2009 | 1153 | 0.190 |
Why?
|
| Polymorphism, Restriction Fragment Length | 8 | 2003 | 767 | 0.190 |
Why?
|
| RNA, Neoplasm | 4 | 2020 | 750 | 0.190 |
Why?
|
| Gene Expression Profiling | 11 | 2018 | 9510 | 0.190 |
Why?
|
| Telomerase | 2 | 2004 | 752 | 0.190 |
Why?
|
| Carcinoma, Neuroendocrine | 3 | 2001 | 342 | 0.190 |
Why?
|
| Cell Nucleus | 10 | 2010 | 2886 | 0.190 |
Why?
|
| Herpesvirus 2, Human | 1 | 2002 | 191 | 0.190 |
Why?
|
| Sensitivity and Specificity | 13 | 2024 | 14737 | 0.190 |
Why?
|
| Cell Transformation, Viral | 7 | 2015 | 530 | 0.180 |
Why?
|
| Mullerian Ducts | 3 | 2018 | 203 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2010 | 277 | 0.170 |
Why?
|
| Anal Canal | 3 | 2017 | 376 | 0.170 |
Why?
|
| Microdissection | 3 | 2010 | 151 | 0.170 |
Why?
|
| Adenofibroma | 2 | 2010 | 25 | 0.170 |
Why?
|
| Alphapapillomavirus | 2 | 2013 | 218 | 0.170 |
Why?
|
| RNA Helicases | 1 | 2000 | 144 | 0.170 |
Why?
|
| Reproducibility of Results | 12 | 2015 | 20224 | 0.170 |
Why?
|
| Neurodermatitis | 1 | 2019 | 8 | 0.160 |
Why?
|
| Staining and Labeling | 5 | 2007 | 1081 | 0.160 |
Why?
|
| Transcription Factors | 14 | 2024 | 12166 | 0.160 |
Why?
|
| Sarcoma, Synovial | 1 | 2020 | 156 | 0.160 |
Why?
|
| Tobacco Mosaic Virus | 2 | 1988 | 17 | 0.160 |
Why?
|
| Prognosis | 18 | 2020 | 30022 | 0.160 |
Why?
|
| Gene Rearrangement | 2 | 2024 | 1139 | 0.160 |
Why?
|
| Penile Neoplasms | 3 | 1990 | 158 | 0.160 |
Why?
|
| Choristoma | 1 | 2020 | 205 | 0.160 |
Why?
|
| Mice | 28 | 2023 | 82017 | 0.150 |
Why?
|
| Epidermodysplasia Verruciformis | 1 | 2018 | 22 | 0.150 |
Why?
|
| Papillomavirus E7 Proteins | 5 | 2011 | 110 | 0.150 |
Why?
|
| Intestinal Mucosa | 2 | 2020 | 3048 | 0.150 |
Why?
|
| Antigens, Viral | 11 | 2003 | 992 | 0.150 |
Why?
|
| Sex Cord-Gonadal Stromal Tumors | 1 | 2020 | 118 | 0.150 |
Why?
|
| Endometritis | 4 | 1987 | 49 | 0.150 |
Why?
|
| Adult Stem Cells | 1 | 2020 | 221 | 0.150 |
Why?
|
| Cell Cycle | 3 | 2001 | 2938 | 0.150 |
Why?
|
| Esophageal Neoplasms | 5 | 2019 | 1676 | 0.150 |
Why?
|
| Electrosurgery | 3 | 2014 | 53 | 0.140 |
Why?
|
| Leiomyosarcoma | 3 | 2012 | 425 | 0.140 |
Why?
|
| Embryonic Stem Cells | 3 | 2013 | 1249 | 0.140 |
Why?
|
| Phenotype | 13 | 2018 | 16721 | 0.140 |
Why?
|
| Chorionic Villi | 3 | 2010 | 53 | 0.140 |
Why?
|
| Animals | 47 | 2023 | 169337 | 0.140 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2023 | 520 | 0.140 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2023 | 3243 | 0.140 |
Why?
|
| Neoplasm Invasiveness | 11 | 2018 | 3633 | 0.140 |
Why?
|
| DNA Damage | 6 | 2010 | 2458 | 0.140 |
Why?
|
| Vulvodynia | 1 | 2016 | 7 | 0.140 |
Why?
|
| Placenta Diseases | 2 | 2010 | 199 | 0.140 |
Why?
|
| Uterine Cervicitis | 3 | 1987 | 31 | 0.130 |
Why?
|
| Lung | 5 | 2023 | 10089 | 0.130 |
Why?
|
| Pregnancy Complications, Neoplastic | 3 | 2013 | 259 | 0.130 |
Why?
|
| Syphilis, Congenital | 1 | 1996 | 26 | 0.130 |
Why?
|
| Serum | 1 | 2017 | 207 | 0.130 |
Why?
|
| Leiomyoma | 2 | 2012 | 644 | 0.130 |
Why?
|
| Treponema pallidum | 1 | 1996 | 48 | 0.130 |
Why?
|
| Rhabdoid Tumor | 1 | 2018 | 211 | 0.130 |
Why?
|
| Adenoma | 2 | 2019 | 2163 | 0.130 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2020 | 887 | 0.130 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2018 | 289 | 0.120 |
Why?
|
| Tissue Banks | 1 | 2016 | 184 | 0.120 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2012 | 9063 | 0.120 |
Why?
|
| In Situ Hybridization, Fluorescence | 6 | 2024 | 2524 | 0.120 |
Why?
|
| DNA Primers | 5 | 2003 | 2825 | 0.120 |
Why?
|
| DNA | 4 | 2004 | 7211 | 0.120 |
Why?
|
| Early Diagnosis | 3 | 2012 | 1195 | 0.120 |
Why?
|
| Keratin-5 | 1 | 2014 | 43 | 0.120 |
Why?
|
| Salpingectomy | 1 | 2015 | 45 | 0.120 |
Why?
|
| Organoids | 2 | 2018 | 746 | 0.120 |
Why?
|
| Abortion, Spontaneous | 2 | 2001 | 539 | 0.120 |
Why?
|
| Homosexuality, Female | 1 | 1996 | 171 | 0.120 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2000 | 562 | 0.120 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2017 | 249 | 0.120 |
Why?
|
| Germ-Line Mutation | 3 | 2013 | 1885 | 0.120 |
Why?
|
| Cystic Fibrosis | 1 | 2023 | 1285 | 0.110 |
Why?
|
| Spectrometry, Fluorescence | 5 | 2009 | 694 | 0.110 |
Why?
|
| Terminology as Topic | 4 | 2018 | 1539 | 0.110 |
Why?
|
| Risk Factors | 21 | 2020 | 74962 | 0.110 |
Why?
|
| Disease-Free Survival | 5 | 2019 | 6856 | 0.110 |
Why?
|
| Ribosomal Protein S6 | 1 | 2013 | 70 | 0.110 |
Why?
|
| Genes, ras | 2 | 2007 | 665 | 0.110 |
Why?
|
| Genes, Wilms Tumor | 1 | 1993 | 92 | 0.110 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2013 | 163 | 0.110 |
Why?
|
| Genes, myc | 1 | 1994 | 391 | 0.100 |
Why?
|
| Mesothelioma | 3 | 2018 | 811 | 0.100 |
Why?
|
| Mixed Tumor, Mullerian | 1 | 2012 | 55 | 0.100 |
Why?
|
| MicroRNAs | 2 | 2020 | 3804 | 0.100 |
Why?
|
| DNA Helicases | 1 | 2018 | 853 | 0.100 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2017 | 388 | 0.100 |
Why?
|
| Warts | 5 | 1984 | 66 | 0.100 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2013 | 164 | 0.100 |
Why?
|
| Pulmonary Alveoli | 2 | 2014 | 665 | 0.100 |
Why?
|
| Neoplasm Seeding | 1 | 2012 | 85 | 0.100 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 1667 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligases | 4 | 2013 | 1901 | 0.100 |
Why?
|
| Translocation, Genetic | 1 | 2018 | 1395 | 0.100 |
Why?
|
| Mitosis | 8 | 2008 | 1190 | 0.100 |
Why?
|
| Prostate | 1 | 2020 | 1781 | 0.100 |
Why?
|
| Histocytochemistry | 6 | 2016 | 699 | 0.100 |
Why?
|
| Pathology | 2 | 2008 | 270 | 0.100 |
Why?
|
| Pregnancy | 19 | 2015 | 30200 | 0.100 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 2 | 2014 | 450 | 0.100 |
Why?
|
| Neoplasm Staging | 11 | 2015 | 11254 | 0.090 |
Why?
|
| Antiviral Agents | 1 | 2004 | 3064 | 0.090 |
Why?
|
| Stillbirth | 3 | 2010 | 376 | 0.090 |
Why?
|
| Octamer Transcription Factor-3 | 2 | 2009 | 221 | 0.090 |
Why?
|
| Umbilical Cord | 2 | 2009 | 179 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 6 | 2019 | 6541 | 0.090 |
Why?
|
| Chi-Square Distribution | 2 | 2013 | 3438 | 0.090 |
Why?
|
| Keratin-14 | 2 | 2001 | 57 | 0.090 |
Why?
|
| DNA, Bacterial | 1 | 1996 | 1479 | 0.090 |
Why?
|
| DNA Replication | 3 | 2018 | 1428 | 0.090 |
Why?
|
| Models, Biological | 4 | 2015 | 9493 | 0.090 |
Why?
|
| Genitalia, Female | 2 | 1990 | 146 | 0.090 |
Why?
|
| Immunologic Tests | 1 | 1991 | 104 | 0.090 |
Why?
|
| Keratins | 3 | 2001 | 502 | 0.090 |
Why?
|
| Epigenesis, Genetic | 3 | 2015 | 3827 | 0.090 |
Why?
|
| Genomics | 3 | 2022 | 5916 | 0.090 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2009 | 710 | 0.090 |
Why?
|
| Risk Assessment | 8 | 2013 | 24318 | 0.090 |
Why?
|
| Wilms Tumor | 1 | 1993 | 379 | 0.090 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2010 | 120 | 0.090 |
Why?
|
| Cloning, Molecular | 5 | 2023 | 4168 | 0.090 |
Why?
|
| Fetus | 5 | 2015 | 1883 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 7 | 2020 | 6132 | 0.090 |
Why?
|
| Prevalence | 6 | 2023 | 15872 | 0.090 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2011 | 168 | 0.080 |
Why?
|
| Epididymal Secretory Proteins | 2 | 2010 | 12 | 0.080 |
Why?
|
| Genes, p16 | 1 | 2010 | 160 | 0.080 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 1766 | 0.080 |
Why?
|
| Vulvovaginitis | 1 | 1989 | 14 | 0.080 |
Why?
|
| Retrospective Studies | 15 | 2024 | 81801 | 0.080 |
Why?
|
| Antigen-Antibody Complex | 2 | 2010 | 513 | 0.080 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 1993 | 335 | 0.080 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2010 | 424 | 0.080 |
Why?
|
| Langerhans Cells | 1 | 2010 | 169 | 0.080 |
Why?
|
| Polyps | 2 | 2009 | 200 | 0.080 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2010 | 283 | 0.080 |
Why?
|
| Centrosome | 2 | 2001 | 210 | 0.080 |
Why?
|
| Base Sequence | 9 | 2008 | 12422 | 0.080 |
Why?
|
| Skin | 4 | 2008 | 4499 | 0.080 |
Why?
|
| Salpingitis | 2 | 1987 | 11 | 0.080 |
Why?
|
| Carcinoma, Papillary | 2 | 2007 | 793 | 0.080 |
Why?
|
| Clone Cells | 3 | 2018 | 1671 | 0.080 |
Why?
|
| Acetates | 2 | 1990 | 317 | 0.080 |
Why?
|
| DNA Repair | 1 | 2018 | 2048 | 0.080 |
Why?
|
| Wolffian Ducts | 2 | 2019 | 27 | 0.080 |
Why?
|
| Penis | 1 | 1990 | 210 | 0.080 |
Why?
|
| Contraception | 1 | 1992 | 362 | 0.080 |
Why?
|
| Molecular Sequence Data | 8 | 2008 | 17626 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 4 | 2013 | 6234 | 0.080 |
Why?
|
| Oocytes | 2 | 2006 | 1171 | 0.080 |
Why?
|
| Mast Cells | 1 | 2016 | 1407 | 0.080 |
Why?
|
| STAT1 Transcription Factor | 1 | 2010 | 343 | 0.080 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2010 | 117 | 0.080 |
Why?
|
| Exons | 2 | 2019 | 2392 | 0.080 |
Why?
|
| Boston | 3 | 2017 | 9371 | 0.080 |
Why?
|
| Chlamydia | 2 | 1985 | 33 | 0.080 |
Why?
|
| Blotting, Southern | 3 | 1996 | 777 | 0.080 |
Why?
|
| Iron | 1 | 2017 | 1814 | 0.080 |
Why?
|
| Transcription, Genetic | 3 | 2012 | 7599 | 0.080 |
Why?
|
| Cystadenoma, Serous | 1 | 2008 | 100 | 0.070 |
Why?
|
| DNA Copy Number Variations | 4 | 2019 | 2046 | 0.070 |
Why?
|
| Decidua | 1 | 2008 | 82 | 0.070 |
Why?
|
| Survival Rate | 4 | 2020 | 12870 | 0.070 |
Why?
|
| Histones | 2 | 2009 | 2592 | 0.070 |
Why?
|
| Struma Ovarii | 1 | 2007 | 10 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2012 | 5037 | 0.070 |
Why?
|
| Proteomics | 2 | 2023 | 3906 | 0.070 |
Why?
|
| Adolescent | 20 | 2024 | 89184 | 0.070 |
Why?
|
| Antigens, Nuclear | 2 | 2000 | 183 | 0.070 |
Why?
|
| Obstetric Labor Complications | 1 | 2010 | 243 | 0.070 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2008 | 121 | 0.070 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2009 | 285 | 0.070 |
Why?
|
| Carcinoembryonic Antigen | 4 | 2001 | 338 | 0.070 |
Why?
|
| Bronchi | 1 | 2011 | 849 | 0.070 |
Why?
|
| Umbilical Veins | 1 | 2008 | 425 | 0.070 |
Why?
|
| Homeodomain Proteins | 2 | 2024 | 2429 | 0.070 |
Why?
|
| Carcinoma, Small Cell | 2 | 2007 | 420 | 0.070 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2010 | 1151 | 0.070 |
Why?
|
| Plant Diseases | 1 | 1988 | 184 | 0.070 |
Why?
|
| Cell Line, Tumor | 5 | 2015 | 17135 | 0.070 |
Why?
|
| RNA, Double-Stranded | 1 | 1988 | 293 | 0.070 |
Why?
|
| Gynecology | 1 | 1993 | 533 | 0.070 |
Why?
|
| Genes, Viral | 5 | 2002 | 655 | 0.070 |
Why?
|
| Ovarian Diseases | 1 | 2008 | 137 | 0.070 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1988 | 706 | 0.070 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 1999 | 2185 | 0.070 |
Why?
|
| Radiotherapy Dosage | 2 | 2013 | 2922 | 0.070 |
Why?
|
| DNA Probes | 3 | 2010 | 542 | 0.070 |
Why?
|
| Follow-Up Studies | 10 | 2018 | 39407 | 0.070 |
Why?
|
| Apoptosis | 5 | 2020 | 9516 | 0.070 |
Why?
|
| Organ Specificity | 2 | 2001 | 1967 | 0.070 |
Why?
|
| Fetal Death | 1 | 2008 | 438 | 0.070 |
Why?
|
| Conization | 1 | 2005 | 18 | 0.070 |
Why?
|
| Plant Proteins | 1 | 1988 | 376 | 0.070 |
Why?
|
| Intestines | 1 | 2015 | 1912 | 0.070 |
Why?
|
| Postmenopause | 1 | 1995 | 2518 | 0.060 |
Why?
|
| Disease Models, Animal | 7 | 2013 | 18362 | 0.060 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2008 | 256 | 0.060 |
Why?
|
| Hair Follicle | 1 | 2008 | 219 | 0.060 |
Why?
|
| Random Allocation | 1 | 2010 | 2397 | 0.060 |
Why?
|
| Specimen Handling | 2 | 2009 | 708 | 0.060 |
Why?
|
| Regeneration | 1 | 2014 | 1525 | 0.060 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2010 | 620 | 0.060 |
Why?
|
| Spouses | 1 | 2007 | 286 | 0.060 |
Why?
|
| Age Factors | 9 | 2015 | 18471 | 0.060 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 2 | 2009 | 494 | 0.060 |
Why?
|
| Meiosis | 1 | 2006 | 327 | 0.060 |
Why?
|
| Fetal Diseases | 1 | 2010 | 916 | 0.060 |
Why?
|
| Cells, Cultured | 8 | 2016 | 19022 | 0.060 |
Why?
|
| Young Adult | 9 | 2024 | 60049 | 0.060 |
Why?
|
| Antigen Presentation | 1 | 2010 | 1251 | 0.060 |
Why?
|
| Melanocytes | 1 | 2008 | 508 | 0.060 |
Why?
|
| Constriction, Pathologic | 1 | 2008 | 1104 | 0.060 |
Why?
|
| Blood Vessels | 1 | 2010 | 1110 | 0.060 |
Why?
|
| Placenta Accreta | 1 | 2008 | 241 | 0.060 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2024 | 61 | 0.060 |
Why?
|
| RNA, Messenger | 7 | 2008 | 12805 | 0.060 |
Why?
|
| Cell Division | 3 | 2000 | 4479 | 0.060 |
Why?
|
| Incidental Findings | 1 | 2009 | 698 | 0.060 |
Why?
|
| Epithelioid Cells | 1 | 2024 | 60 | 0.060 |
Why?
|
| Esophageal Diseases | 1 | 1985 | 168 | 0.060 |
Why?
|
| Keratinocytes | 3 | 2003 | 876 | 0.060 |
Why?
|
| Cell Cycle Proteins | 3 | 2013 | 3458 | 0.060 |
Why?
|
| Cell Survival | 2 | 2013 | 5792 | 0.060 |
Why?
|
| Membrane Glycoproteins | 3 | 2010 | 3712 | 0.060 |
Why?
|
| Task Performance and Analysis | 1 | 2008 | 771 | 0.060 |
Why?
|
| Gene Expression | 3 | 2001 | 7598 | 0.050 |
Why?
|
| Spectrum Analysis | 2 | 2004 | 449 | 0.050 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2020 | 1105 | 0.050 |
Why?
|
| Treatment Outcome | 10 | 2019 | 65379 | 0.050 |
Why?
|
| Cysts | 2 | 2008 | 685 | 0.050 |
Why?
|
| Virus Integration | 2 | 2013 | 306 | 0.050 |
Why?
|
| Gestational Age | 5 | 2013 | 3615 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2010 | 1658 | 0.050 |
Why?
|
| Exocrine Glands | 1 | 2002 | 46 | 0.050 |
Why?
|
| Antigens, Bacterial | 2 | 1985 | 1150 | 0.050 |
Why?
|
| Ploidies | 5 | 2010 | 287 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2010 | 1248 | 0.050 |
Why?
|
| HMGA2 Protein | 1 | 2003 | 101 | 0.050 |
Why?
|
| Clitoris | 1 | 2002 | 35 | 0.050 |
Why?
|
| Sexual Behavior | 1 | 1992 | 2200 | 0.050 |
Why?
|
| X Chromosome | 2 | 1997 | 819 | 0.050 |
Why?
|
| Cell Movement | 3 | 2010 | 5215 | 0.050 |
Why?
|
| Protein Precursors | 1 | 1987 | 1134 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2018 | 11854 | 0.050 |
Why?
|
| Students | 1 | 1992 | 1744 | 0.050 |
Why?
|
| Urinary Bladder Fistula | 1 | 1982 | 10 | 0.050 |
Why?
|
| Reference Values | 4 | 2004 | 4941 | 0.050 |
Why?
|
| Vaccination | 2 | 2006 | 3431 | 0.050 |
Why?
|
| Pregnancy Outcome | 2 | 2010 | 2961 | 0.050 |
Why?
|
| Case-Control Studies | 5 | 2016 | 22296 | 0.050 |
Why?
|
| Statistics as Topic | 2 | 2005 | 2363 | 0.050 |
Why?
|
| Antigens, CD | 2 | 2010 | 4031 | 0.050 |
Why?
|
| Gene Dosage | 2 | 2016 | 1221 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 3707 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2010 | 1753 | 0.050 |
Why?
|
| Thrombosis | 3 | 2010 | 2955 | 0.050 |
Why?
|
| Male | 32 | 2020 | 364902 | 0.050 |
Why?
|
| Protein Kinases | 1 | 1988 | 1609 | 0.050 |
Why?
|
| Myofibroblasts | 1 | 2023 | 229 | 0.050 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2004 | 640 | 0.050 |
Why?
|
| Artifacts | 1 | 2010 | 1930 | 0.050 |
Why?
|
| Autoantibodies | 1 | 2010 | 2126 | 0.050 |
Why?
|
| Contraceptives, Oral | 1 | 2003 | 562 | 0.050 |
Why?
|
| Herpesviridae Infections | 1 | 1982 | 269 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2003 | 413 | 0.050 |
Why?
|
| Protein Biosynthesis | 1 | 1988 | 2094 | 0.050 |
Why?
|
| NADP | 1 | 2002 | 230 | 0.050 |
Why?
|
| Mucin-2 | 1 | 2000 | 50 | 0.050 |
Why?
|
| Gene Products, env | 1 | 2001 | 250 | 0.040 |
Why?
|
| Carcinoma, Large Cell | 1 | 2001 | 114 | 0.040 |
Why?
|
| Cryptococcosis | 1 | 1981 | 103 | 0.040 |
Why?
|
| Genome, Human | 1 | 2013 | 4450 | 0.040 |
Why?
|
| Cryosurgery | 2 | 1985 | 477 | 0.040 |
Why?
|
| Atrophy | 2 | 2008 | 1648 | 0.040 |
Why?
|
| Pregnancy Proteins | 1 | 2001 | 223 | 0.040 |
Why?
|
| Intraoperative Complications | 1 | 2007 | 1176 | 0.040 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2023 | 450 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 2 | 2004 | 1614 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2007 | 2604 | 0.040 |
Why?
|
| Mucin 5AC | 1 | 2000 | 96 | 0.040 |
Why?
|
| Gonads | 1 | 2000 | 109 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 4414 | 0.040 |
Why?
|
| Influenza, Human | 1 | 2011 | 1539 | 0.040 |
Why?
|
| Physical Chromosome Mapping | 1 | 2000 | 183 | 0.040 |
Why?
|
| Skin Neoplasms | 4 | 2003 | 5857 | 0.040 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2020 | 46 | 0.040 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2020 | 42 | 0.040 |
Why?
|
| Plasma Cells | 1 | 1983 | 599 | 0.040 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2020 | 40 | 0.040 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2001 | 287 | 0.040 |
Why?
|
| Fistula | 1 | 1982 | 213 | 0.040 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 1985 | 470 | 0.040 |
Why?
|
| Capsid Proteins | 2 | 2015 | 468 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2004 | 1585 | 0.040 |
Why?
|
| Immunologic Techniques | 2 | 1990 | 213 | 0.040 |
Why?
|
| Neoplasms | 3 | 2010 | 22385 | 0.040 |
Why?
|
| WT1 Proteins | 2 | 2007 | 184 | 0.040 |
Why?
|
| Risk | 3 | 2010 | 9636 | 0.040 |
Why?
|
| Combined Modality Therapy | 4 | 2006 | 8562 | 0.040 |
Why?
|
| Oncogene Fusion | 1 | 2020 | 83 | 0.040 |
Why?
|
| Genomic Imprinting | 1 | 2001 | 324 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 2 | 2015 | 1608 | 0.040 |
Why?
|
| Meningitis | 1 | 1981 | 219 | 0.040 |
Why?
|
| Phosphorylation | 4 | 2013 | 8326 | 0.040 |
Why?
|
| Forelimb | 1 | 1999 | 116 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2000 | 387 | 0.040 |
Why?
|
| Peritonitis | 1 | 1981 | 368 | 0.040 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 13576 | 0.040 |
Why?
|
| Quality Control | 2 | 2008 | 833 | 0.040 |
Why?
|
| Cerebral Ventricles | 1 | 1981 | 550 | 0.040 |
Why?
|
| Polyomaviridae | 1 | 1998 | 9 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-kit | 2 | 2016 | 725 | 0.040 |
Why?
|
| Plasmids | 3 | 2003 | 2268 | 0.040 |
Why?
|
| Genital Neoplasms, Male | 1 | 1998 | 68 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 2020 | 1086 | 0.040 |
Why?
|
| Consensus | 1 | 2008 | 3212 | 0.040 |
Why?
|
| Omentum | 1 | 2019 | 168 | 0.040 |
Why?
|
| Gene Frequency | 2 | 2010 | 3617 | 0.040 |
Why?
|
| Online Systems | 1 | 2019 | 182 | 0.040 |
Why?
|
| Time Factors | 6 | 2018 | 40272 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2006 | 10377 | 0.040 |
Why?
|
| Diagnostic Errors | 2 | 2003 | 1280 | 0.040 |
Why?
|
| beta-Defensins | 2 | 2010 | 59 | 0.040 |
Why?
|
| Sulfur Radioisotopes | 2 | 1988 | 113 | 0.040 |
Why?
|
| Referral and Consultation | 2 | 2008 | 3627 | 0.040 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2007 | 2058 | 0.040 |
Why?
|
| Proteins | 1 | 2012 | 6006 | 0.040 |
Why?
|
| Osteosarcoma | 2 | 2001 | 911 | 0.040 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2000 | 384 | 0.040 |
Why?
|
| Dilatation, Pathologic | 2 | 2009 | 527 | 0.040 |
Why?
|
| Protoporphyrins | 1 | 1997 | 170 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2001 | 1753 | 0.040 |
Why?
|
| Child | 5 | 2024 | 80891 | 0.040 |
Why?
|
| Menstrual Cycle | 1 | 2001 | 545 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2003 | 3632 | 0.030 |
Why?
|
| Immunotherapy | 2 | 2003 | 4738 | 0.030 |
Why?
|
| Intestine, Small | 2 | 2015 | 1218 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 6971 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 1999 | 444 | 0.030 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2020 | 462 | 0.030 |
Why?
|
| Introns | 1 | 2019 | 968 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2002 | 2695 | 0.030 |
Why?
|
| Hindlimb | 1 | 1999 | 516 | 0.030 |
Why?
|
| Inflammation | 3 | 2023 | 10863 | 0.030 |
Why?
|
| Aminolevulinic Acid | 1 | 1997 | 150 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2006 | 6350 | 0.030 |
Why?
|
| Fibrosarcoma | 1 | 1978 | 313 | 0.030 |
Why?
|
| Transsexualism | 1 | 2020 | 210 | 0.030 |
Why?
|
| Societies, Medical | 2 | 2019 | 3960 | 0.030 |
Why?
|
| Vagina | 2 | 1995 | 845 | 0.030 |
Why?
|
| Hematoxylin | 1 | 1996 | 61 | 0.030 |
Why?
|
| Kidney Neoplasms | 1 | 1993 | 4303 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2011 | 9562 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2018 | 796 | 0.030 |
Why?
|
| Otorhinolaryngologic Neoplasms | 1 | 1996 | 26 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2000 | 2176 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 2010 | 2972 | 0.030 |
Why?
|
| Mycosis Fungoides | 1 | 1977 | 169 | 0.030 |
Why?
|
| Electrophoresis, Agar Gel | 2 | 1986 | 205 | 0.030 |
Why?
|
| Genotype | 3 | 2023 | 13042 | 0.030 |
Why?
|
| Pneumonia | 2 | 2020 | 2163 | 0.030 |
Why?
|
| Fetal Growth Retardation | 2 | 2010 | 591 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 697 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 1 | 2020 | 581 | 0.030 |
Why?
|
| Open Reading Frames | 3 | 1994 | 812 | 0.030 |
Why?
|
| Taiwan | 1 | 1997 | 528 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2017 | 9198 | 0.030 |
Why?
|
| Carboplatin | 1 | 2018 | 799 | 0.030 |
Why?
|
| Viral Proteins | 3 | 2004 | 1802 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2020 | 1078 | 0.030 |
Why?
|
| Bronchioles | 1 | 2014 | 25 | 0.030 |
Why?
|
| Hong Kong | 1 | 2015 | 168 | 0.030 |
Why?
|
| Cell Biology | 1 | 1995 | 92 | 0.030 |
Why?
|
| Cytoplasm | 2 | 2008 | 1502 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2001 | 1748 | 0.030 |
Why?
|
| Pregnancy, Multiple | 1 | 1995 | 216 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 2006 | 13423 | 0.030 |
Why?
|
| Histological Techniques | 2 | 2005 | 194 | 0.030 |
Why?
|
| Hormone Replacement Therapy | 1 | 2020 | 756 | 0.030 |
Why?
|
| Body Patterning | 1 | 1999 | 634 | 0.030 |
Why?
|
| Viral Load | 1 | 2004 | 3398 | 0.030 |
Why?
|
| Y Chromosome | 1 | 1995 | 205 | 0.030 |
Why?
|
| Chorionic Gonadotropin | 3 | 1982 | 458 | 0.030 |
Why?
|
| Skull | 1 | 1999 | 831 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 3 | 1992 | 3731 | 0.030 |
Why?
|
| Core Binding Factor beta Subunit | 1 | 2013 | 42 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2001 | 1409 | 0.030 |
Why?
|
| Simplexvirus | 3 | 1982 | 805 | 0.030 |
Why?
|
| Sarcoma | 2 | 1984 | 1807 | 0.030 |
Why?
|
| Deoxycytidine | 1 | 2018 | 888 | 0.030 |
Why?
|
| Biological Products | 1 | 2003 | 934 | 0.030 |
Why?
|
| Vulvar Lichen Sclerosus | 1 | 2013 | 11 | 0.030 |
Why?
|
| Cisplatin | 2 | 2015 | 1661 | 0.030 |
Why?
|
| Sexually Transmitted Diseases | 2 | 1992 | 666 | 0.030 |
Why?
|
| Flow Cytometry | 3 | 2013 | 5900 | 0.030 |
Why?
|
| Collagen | 1 | 2002 | 2646 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2015 | 551 | 0.030 |
Why?
|
| Choriocarcinoma | 1 | 2014 | 121 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 1996 | 584 | 0.030 |
Why?
|
| Coloring Agents | 1 | 1996 | 564 | 0.030 |
Why?
|
| Human papillomavirus 11 | 1 | 2013 | 14 | 0.030 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2013 | 125 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 1 | 2007 | 2923 | 0.030 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2015 | 264 | 0.030 |
Why?
|
| Photosensitizing Agents | 1 | 1997 | 631 | 0.030 |
Why?
|
| Paired Box Transcription Factors | 1 | 2013 | 206 | 0.030 |
Why?
|
| Culture Media | 1 | 2015 | 898 | 0.030 |
Why?
|
| Oviducts | 1 | 2012 | 11 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2004 | 12456 | 0.030 |
Why?
|
| Cell Separation | 1 | 2018 | 1726 | 0.030 |
Why?
|
| Androgens | 1 | 2020 | 1285 | 0.030 |
Why?
|
| Virginia | 1 | 1992 | 115 | 0.030 |
Why?
|
| Fibrosis | 1 | 2020 | 2077 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2013 | 314 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2015 | 720 | 0.030 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2013 | 62 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2018 | 863 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 1994 | 395 | 0.030 |
Why?
|
| Co-Repressor Proteins | 1 | 2013 | 190 | 0.030 |
Why?
|
| Pyrazines | 1 | 2018 | 1206 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2023 | 4177 | 0.030 |
Why?
|
| Aortic Diseases | 1 | 1978 | 741 | 0.030 |
Why?
|
| HLA-B Antigens | 1 | 2013 | 328 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2004 | 3471 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2013 | 867 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2016 | 1605 | 0.020 |
Why?
|
| Tumor Microenvironment | 2 | 2018 | 3939 | 0.020 |
Why?
|
| Acetic Acid | 2 | 1990 | 59 | 0.020 |
Why?
|
| Antibodies | 1 | 2000 | 2425 | 0.020 |
Why?
|
| Laser Therapy | 3 | 1985 | 1105 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 3617 | 0.020 |
Why?
|
| F-Box Proteins | 1 | 2013 | 201 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2000 | 3612 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2013 | 478 | 0.020 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2014 | 255 | 0.020 |
Why?
|
| Pre-Eclampsia | 1 | 2001 | 1255 | 0.020 |
Why?
|
| Virus Latency | 1 | 1995 | 360 | 0.020 |
Why?
|
| New England | 1 | 2015 | 1058 | 0.020 |
Why?
|
| Reproductive History | 1 | 2013 | 210 | 0.020 |
Why?
|
| Laminin | 1 | 2013 | 406 | 0.020 |
Why?
|
| Spectrophotometry | 2 | 1989 | 292 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1993 | 1553 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 7453 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 2206 | 0.020 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2013 | 427 | 0.020 |
Why?
|
| Integrases | 1 | 2013 | 520 | 0.020 |
Why?
|
| Virus Replication | 2 | 1990 | 2458 | 0.020 |
Why?
|
| ROC Curve | 2 | 2010 | 3623 | 0.020 |
Why?
|
| Scattering, Radiation | 2 | 2004 | 489 | 0.020 |
Why?
|
| Photochemotherapy | 1 | 1997 | 830 | 0.020 |
Why?
|
| Microscopy | 1 | 2016 | 909 | 0.020 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2013 | 378 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 3722 | 0.020 |
Why?
|
| Tissue Embedding | 1 | 2010 | 43 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2015 | 715 | 0.020 |
Why?
|
| Methionine | 1 | 2013 | 573 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2013 | 5801 | 0.020 |
Why?
|
| Phthalazines | 1 | 2013 | 397 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2011 | 455 | 0.020 |
Why?
|
| Oligohydramnios | 1 | 2010 | 37 | 0.020 |
Why?
|
| Immunoglobulins | 2 | 2010 | 855 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2002 | 14481 | 0.020 |
Why?
|
| Nuchal Cord | 1 | 2009 | 5 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 4588 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2013 | 640 | 0.020 |
Why?
|
| Receptors, Progesterone | 2 | 2008 | 1145 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2002 | 2257 | 0.020 |
Why?
|
| Transfection | 2 | 2015 | 5764 | 0.020 |
Why?
|
| Esophagogastric Junction | 1 | 2012 | 349 | 0.020 |
Why?
|
| Dogs | 1 | 2014 | 3846 | 0.020 |
Why?
|
| Computational Biology | 1 | 2001 | 3543 | 0.020 |
Why?
|
| Serologic Tests | 1 | 1992 | 383 | 0.020 |
Why?
|
| Genes, Homeobox | 1 | 2011 | 289 | 0.020 |
Why?
|
| Bacterial Toxins | 1 | 2015 | 923 | 0.020 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2018 | 1614 | 0.020 |
Why?
|
| Cytogenetic Analysis | 1 | 2010 | 270 | 0.020 |
Why?
|
| Chorion | 1 | 2009 | 112 | 0.020 |
Why?
|
| Apgar Score | 1 | 2009 | 126 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2000 | 2986 | 0.020 |
Why?
|
| Testosterone | 1 | 2020 | 2493 | 0.020 |
Why?
|
| Gene Amplification | 1 | 1994 | 1090 | 0.020 |
Why?
|
| Heart Rate, Fetal | 1 | 2009 | 76 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2012 | 598 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2023 | 42650 | 0.020 |
Why?
|
| Premenopause | 1 | 2013 | 1039 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2016 | 12558 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2010 | 738 | 0.020 |
Why?
|
| Algorithms | 1 | 2009 | 14154 | 0.020 |
Why?
|
| Gene Expression Regulation | 3 | 2001 | 11918 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2010 | 4142 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 4775 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2533 | 0.020 |
Why?
|
| Epidermis | 2 | 2003 | 539 | 0.020 |
Why?
|
| MART-1 Antigen | 1 | 2008 | 62 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2013 | 1837 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2010 | 348 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2013 | 1135 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2018 | 2021 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2015 | 1736 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2013 | 1337 | 0.020 |
Why?
|
| Tonsillar Neoplasms | 1 | 2007 | 50 | 0.020 |
Why?
|
| Antineoplastic Agents | 3 | 2004 | 13697 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2019 | 2909 | 0.020 |
Why?
|
| Signal Transduction | 4 | 2015 | 23631 | 0.020 |
Why?
|
| Amniotic Fluid | 1 | 2009 | 381 | 0.020 |
Why?
|
| Dilatation and Curettage | 2 | 1984 | 53 | 0.020 |
Why?
|
| Neutrophils | 1 | 2020 | 3785 | 0.020 |
Why?
|
| Universities | 1 | 1992 | 1005 | 0.020 |
Why?
|
| Colon | 1 | 2015 | 1805 | 0.020 |
Why?
|
| Maternal Age | 1 | 2010 | 809 | 0.020 |
Why?
|
| Laparoscopy | 2 | 2010 | 2056 | 0.020 |
Why?
|
| Biotin | 1 | 1988 | 256 | 0.020 |
Why?
|
| Proctitis | 1 | 1987 | 40 | 0.020 |
Why?
|
| Pedigree | 1 | 2014 | 4544 | 0.020 |
Why?
|
| Wound Healing | 2 | 2011 | 2813 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 4646 | 0.020 |
Why?
|
| RNA Interference | 1 | 2015 | 2836 | 0.020 |
Why?
|
| Estrogens | 2 | 2011 | 1534 | 0.020 |
Why?
|
| Inhibins | 1 | 2007 | 210 | 0.020 |
Why?
|
| Receptors, Estrogen | 2 | 2008 | 2247 | 0.020 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 1987 | 96 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2009 | 695 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1988 | 2172 | 0.020 |
Why?
|
| Oogenesis | 1 | 2006 | 125 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1988 | 1731 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2014 | 1602 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2012 | 1110 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 1642 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2007 | 228 | 0.020 |
Why?
|
| Simian virus 40 | 1 | 1986 | 292 | 0.020 |
Why?
|
| Recurrence | 1 | 1998 | 8506 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 2830 | 0.020 |
Why?
|
| Incidence | 2 | 2018 | 21544 | 0.020 |
Why?
|
| Prospective Studies | 4 | 2017 | 54920 | 0.020 |
Why?
|
| Immune System | 1 | 1991 | 801 | 0.020 |
Why?
|
| Remission, Spontaneous | 1 | 1986 | 385 | 0.020 |
Why?
|
| Sirolimus | 1 | 2012 | 1542 | 0.020 |
Why?
|
| Chlamydia trachomatis | 1 | 1987 | 239 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 1977 | 2565 | 0.020 |
Why?
|
| Organ Size | 1 | 2010 | 2268 | 0.020 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2009 | 518 | 0.010 |
Why?
|
| Cohort Studies | 3 | 2016 | 41795 | 0.010 |
Why?
|
| Immunity | 1 | 1991 | 1003 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2012 | 2673 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2008 | 1502 | 0.010 |
Why?
|
| Consultants | 1 | 1984 | 57 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2008 | 1376 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 22355 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2007 | 1539 | 0.010 |
Why?
|
| Coitus | 1 | 1984 | 133 | 0.010 |
Why?
|
| Digestive System Neoplasms | 1 | 2004 | 83 | 0.010 |
Why?
|
| Optical Fibers | 1 | 2004 | 135 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2012 | 2066 | 0.010 |
Why?
|
| Rats | 2 | 2011 | 23835 | 0.010 |
Why?
|
| Vacuoles | 1 | 1984 | 224 | 0.010 |
Why?
|
| Ligands | 1 | 2010 | 3283 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 2003 | 397 | 0.010 |
Why?
|
| Receptor, erbB-2 | 1 | 2013 | 2588 | 0.010 |
Why?
|
| Plasminogen | 1 | 2003 | 144 | 0.010 |
Why?
|
| Oxygen | 1 | 2014 | 4273 | 0.010 |
Why?
|
| Microscopy, Electron | 3 | 1982 | 2559 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 2 | 2010 | 9261 | 0.010 |
Why?
|
| Cytodiagnosis | 1 | 1987 | 453 | 0.010 |
Why?
|
| Cell Communication | 1 | 2010 | 1660 | 0.010 |
Why?
|
| GPI-Linked Proteins | 1 | 2004 | 473 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2003 | 413 | 0.010 |
Why?
|
| Capsules | 1 | 2003 | 193 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3813 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 2008 | 936 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12092 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2017 | 4421 | 0.010 |
Why?
|
| Piperazines | 1 | 2013 | 2552 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 2004 | 556 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 2750 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1987 | 2475 | 0.010 |
Why?
|
| Receptor, Notch2 | 1 | 2002 | 90 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2003 | 616 | 0.010 |
Why?
|
| Fiber Optic Technology | 1 | 2004 | 291 | 0.010 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2002 | 133 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2001 | 43 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2007 | 1266 | 0.010 |
Why?
|
| Diffusion | 1 | 2004 | 818 | 0.010 |
Why?
|
| Medical Errors | 1 | 2010 | 1263 | 0.010 |
Why?
|
| Cervix Mucus | 1 | 1981 | 18 | 0.010 |
Why?
|
| Protozoan Infections | 1 | 1981 | 38 | 0.010 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2012 | 1671 | 0.010 |
Why?
|
| Sex Offenses | 1 | 1986 | 358 | 0.010 |
Why?
|
| Age Distribution | 1 | 2007 | 2877 | 0.010 |
Why?
|
| Organoplatinum Compounds | 1 | 2003 | 408 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2013 | 4526 | 0.010 |
Why?
|
| Aging | 1 | 2000 | 8764 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2004 | 10776 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2007 | 1674 | 0.010 |
Why?
|
| Cell Death | 1 | 2006 | 1682 | 0.010 |
Why?
|
| Mouth | 1 | 2004 | 383 | 0.010 |
Why?
|
| Drugs, Investigational | 1 | 2003 | 213 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2003 | 1065 | 0.010 |
Why?
|
| Virion | 1 | 2003 | 430 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 2002 | 321 | 0.010 |
Why?
|
| Risk Reduction Behavior | 1 | 2007 | 1118 | 0.010 |
Why?
|
| Centrioles | 1 | 2001 | 80 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 1987 | 1478 | 0.010 |
Why?
|
| Cesarean Section | 1 | 2009 | 1417 | 0.010 |
Why?
|
| Cryptococcus neoformans | 1 | 1981 | 121 | 0.010 |
Why?
|
| Mouth Mucosa | 1 | 2003 | 437 | 0.010 |
Why?
|
| Hematuria | 1 | 1982 | 233 | 0.010 |
Why?
|
| Urothelium | 1 | 2002 | 276 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 16028 | 0.010 |
Why?
|
| Necrosis | 1 | 1984 | 1621 | 0.010 |
Why?
|
| Eosinophilia | 1 | 2004 | 556 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2003 | 943 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 2010 | 2181 | 0.010 |
Why?
|
| Taxoids | 1 | 2003 | 668 | 0.010 |
Why?
|
| Mucin-1 | 1 | 2004 | 538 | 0.010 |
Why?
|
| Etoposide | 1 | 2001 | 639 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 2002 | 662 | 0.010 |
Why?
|
| Fluorescence | 1 | 2002 | 759 | 0.010 |
Why?
|
| Receptor, Notch1 | 1 | 2002 | 520 | 0.010 |
Why?
|
| alpha-Fetoproteins | 1 | 1980 | 228 | 0.010 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 1999 | 62 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2010 | 5496 | 0.010 |
Why?
|
| Urinary Tract | 1 | 2002 | 305 | 0.010 |
Why?
|
| Limb Buds | 1 | 1999 | 76 | 0.010 |
Why?
|
| Particle Size | 1 | 2003 | 1653 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1991 | 1056 | 0.010 |
Why?
|
| Vincristine | 1 | 2001 | 1040 | 0.010 |
Why?
|
| Postoperative Care | 1 | 1985 | 1480 | 0.010 |
Why?
|
| Probability | 1 | 2004 | 2482 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2003 | 1627 | 0.010 |
Why?
|
| Limb Deformities, Congenital | 1 | 1999 | 136 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1990 | 4211 | 0.010 |
Why?
|
| RNA | 1 | 1988 | 2726 | 0.010 |
Why?
|
| Light | 1 | 2004 | 1354 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2004 | 2079 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2001 | 2299 | 0.010 |
Why?
|
| Cause of Death | 1 | 2008 | 3728 | 0.010 |
Why?
|
| Radiography | 2 | 1978 | 6993 | 0.010 |
Why?
|
| Child Abuse | 1 | 1986 | 1096 | 0.010 |
Why?
|
| Quality of Life | 1 | 2018 | 13503 | 0.010 |
Why?
|
| Craniofacial Abnormalities | 1 | 1999 | 320 | 0.010 |
Why?
|
| Urinary Bladder | 1 | 2002 | 1162 | 0.010 |
Why?
|
| Papilloma, Inverted | 1 | 1996 | 19 | 0.010 |
Why?
|
| Sex Determination Analysis | 1 | 1995 | 46 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2004 | 2925 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 8199 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2004 | 4859 | 0.010 |
Why?
|
| Giant Cell Arteritis | 1 | 1980 | 307 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 12778 | 0.010 |
Why?
|
| Virus Diseases | 1 | 1982 | 723 | 0.010 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1980 | 708 | 0.010 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2002 | 799 | 0.010 |
Why?
|
| Administration, Cutaneous | 1 | 1997 | 715 | 0.010 |
Why?
|
| Comorbidity | 1 | 2010 | 10588 | 0.010 |
Why?
|
| Morphogenesis | 1 | 1999 | 747 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2001 | 2226 | 0.010 |
Why?
|
| Brazil | 1 | 1999 | 1248 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2002 | 2940 | 0.010 |
Why?
|
| Papilloma | 1 | 1996 | 143 | 0.010 |
Why?
|
| Cytokines | 1 | 2010 | 7445 | 0.010 |
Why?
|
| Autopsy | 1 | 1978 | 1013 | 0.010 |
Why?
|
| Massachusetts | 1 | 2008 | 8902 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2001 | 2728 | 0.010 |
Why?
|
| Acute Disease | 1 | 1985 | 7242 | 0.010 |
Why?
|
| Smoking | 1 | 1991 | 9111 | 0.010 |
Why?
|
| Abnormalities, Multiple | 1 | 1982 | 1424 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2001 | 2229 | 0.010 |
Why?
|
| Decision Making | 1 | 2008 | 3953 | 0.010 |
Why?
|
| Twins | 1 | 1995 | 340 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1999 | 1209 | 0.010 |
Why?
|
| Karyotyping | 1 | 1995 | 1173 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2000 | 26411 | 0.010 |
Why?
|
| Nose Neoplasms | 1 | 1996 | 250 | 0.010 |
Why?
|
| Lasers | 3 | 1982 | 952 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 2010 | 4713 | 0.010 |
Why?
|
| North America | 1 | 1997 | 1290 | 0.010 |
Why?
|
| Fibroblast Growth Factors | 1 | 1999 | 873 | 0.010 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 1996 | 290 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 2819 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2008 | 3464 | 0.010 |
Why?
|
| Cell Count | 1 | 1996 | 1833 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2001 | 3553 | 0.010 |
Why?
|
| Laryngeal Neoplasms | 1 | 1996 | 515 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 1978 | 1112 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2004 | 5151 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2003 | 3211 | 0.010 |
Why?
|
| Information Systems | 1 | 1973 | 400 | 0.010 |
Why?
|
| Infant | 1 | 1993 | 36510 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1991 | 849 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 1997 | 2636 | 0.010 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 1983 | 2537 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2008 | 5375 | 0.010 |
Why?
|
| Internet | 1 | 2001 | 3107 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1983 | 9379 | 0.000 |
Why?
|
| Immunoblotting | 1 | 1991 | 1647 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1988 | 548 | 0.000 |
Why?
|
| Carbon Dioxide | 2 | 1982 | 1149 | 0.000 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1991 | 792 | 0.000 |
Why?
|
| Crohn Disease | 1 | 1980 | 2293 | 0.000 |
Why?
|
| Genetic Variation | 1 | 2001 | 6606 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 2003 | 10267 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 36849 | 0.000 |
Why?
|
| Actuarial Analysis | 1 | 1984 | 372 | 0.000 |
Why?
|
| Iodine | 1 | 1984 | 286 | 0.000 |
Why?
|
| Capsid | 1 | 1984 | 435 | 0.000 |
Why?
|
| Cautery | 1 | 1981 | 73 | 0.000 |
Why?
|
| Brenner Tumor | 1 | 1981 | 9 | 0.000 |
Why?
|
| Cystadenoma | 1 | 1981 | 77 | 0.000 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1982 | 946 | 0.000 |
Why?
|
| Desmosomes | 1 | 1980 | 73 | 0.000 |
Why?
|
| Aneuploidy | 1 | 1984 | 572 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1982 | 1629 | 0.000 |
Why?
|
| Periodicity | 1 | 1981 | 348 | 0.000 |
Why?
|
| Teratoma | 1 | 1982 | 405 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1981 | 15881 | 0.000 |
Why?
|
| Arteritis | 1 | 1980 | 158 | 0.000 |
Why?
|
| Progesterone | 1 | 1982 | 751 | 0.000 |
Why?
|
| Japan | 1 | 1982 | 1418 | 0.000 |
Why?
|
| Ileum | 1 | 1980 | 558 | 0.000 |
Why?
|
| Cell Line | 1 | 1991 | 15597 | 0.000 |
Why?
|
| Cilia | 1 | 1981 | 498 | 0.000 |
Why?
|
| Epitopes | 1 | 1981 | 2525 | 0.000 |
Why?
|
| Arteries | 1 | 1980 | 1126 | 0.000 |
Why?
|
| Chemistry | 1 | 1973 | 327 | 0.000 |
Why?
|
| Chemical Phenomena | 1 | 1973 | 486 | 0.000 |
Why?
|
| Data Display | 1 | 1973 | 174 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1980 | 2611 | 0.000 |
Why?
|
| Pain, Postoperative | 1 | 1982 | 1765 | 0.000 |
Why?
|
| Computers | 1 | 1973 | 592 | 0.000 |
Why?
|